Executive Branch

HHS Cancels 22 MRNA Vaccine Development Contracts

The mRNA development activities, managed under the Biomedical Advanced Research and Development Authority, are worth nearly $500 million.
HHS Cancels 22 MRNA Vaccine Development Contracts
Secretary of Health and Human Services Robert F. Kennedy Jr., testifies during a House Energy and Commerce Committee in Washington, on June 24, 2025. AP Photo/Mariam Zuhaib
Jeff Louderback
|Updated:
0:00

Health and Human Services Secretary Robert F. Kennedy Jr. announced on Aug. 5 that 22 mRNA vaccine development contracts are being canceled and redirected “because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.”

The mRNA development activities are spearheaded by the Biomedical Advanced Research and Development Authority (BARDA), which is managed by Global Health Investment Corporation (GHIC).

Jeff Louderback
Jeff Louderback
Reporter
Jeff Louderback covers news and features on the White House and executive agencies for The Epoch Times. He also reports on Senate and House elections. A professional journalist since 1990, Jeff has a versatile background that includes covering news and politics, business, professional and college sports, and lifestyle topics for regional and national media outlets.